Steven M Bryce

Title: Innovations of Steven M Bryce

Introduction

Steven M Bryce is an accomplished inventor based in Rochester, NY (US). He holds a total of 9 patents, showcasing his significant contributions to the field of biotechnology and genetic analysis. His work focuses on developing innovative methods for evaluating cellular components, particularly in relation to DNA damage and gene expression.

Latest Patents

One of his latest patents is the "Simplified nuclei analysis platform and biomarker matrix that supports genotoxic mode of action determinations." This invention presents a straightforward method for assessing free eukaryotic cell nuclei for biomarkers indicative of DNA damage, transcription factor activation, and epigenetic modifications. The invention also outlines effective strategies for integrating nuclear biomarkers into a comprehensive matrix of endpoints, which can clarify the primary mode of DNA-damaging activity of genotoxicants. Additionally, the patent describes kits designed for conducting the methods outlined in the invention.

Career Highlights

Throughout his career, Steven has worked with various organizations, including Litron Laboratories Ltd. His experience in these companies has allowed him to refine his skills and contribute to significant advancements in the field of genetic research.

Collaborations

Steven has collaborated with notable professionals in his field, including Stephen D Dertinger and Jeffrey C Bemis. These partnerships have likely enhanced his research and innovation efforts.

Conclusion

Steven M Bryce is a prominent inventor whose work in developing methods for analyzing cellular nuclei has the potential to impact the understanding of DNA damage and gene expression. His contributions through patents and collaborations highlight his dedication to advancing biotechnology.